M. Malmsjo et al., P2X receptors counteract the vasodilatory effects of endothelium derived hyperpolarising factor, EUR J PHARM, 390(1-2), 2000, pp. 173-180
Dilatory responses of extracellular nucleotides were examined in the precon
tracted isolated rat mesenteric artery. Dilatation mediated by endothelium-
derived hyperpolarising factor (EDHF) was studied in the presence of N omeg
a-nitro-L-arginine (L-NOARG) and indomethacin, and was most potently induce
d by the selective P2Y(1) receptor agonist adenosine 5'-O-thiodiphosphate (
ADP beta S), while 2-methylthioadenosine triphosphate (2-MeSATP) and adenos
ine triphosphate (ATP) were almost inactive. However, after P2X receptor de
sensitisation (with alpha beta-methylene-adenosine triphosphate, alpha beta
-MeATP), 2-MeSATP and ATP potently stimulated EDHF-mediated dilatation. Thi
s can be explained by simultaneous activation of endothelial P2Y receptors
that release EDHF, and depolarising P2X receptors on smooth muscle cells. U
ridine triphosphate (UTP) also induced potent dilatation, suggesting EDHF r
elease via P2Y(2)/P2Y(4) receptors. Uridine diphosphate (UDP) had only mino
r dilatory effects, and when pretreated with hexokinase it was almost inact
ive, suggesting a minor role for P2Y(6) receptors. The nitric oxide (NO) me
diated dilatation was studied in the presence of charybdotoxin, apamin and
indomethacin. ADP beta S, 2-MeSATP, ATP and UTP were all potent relaxant ag
onists suggesting NO release via P2Y(1) and P2Y(2)/P2Y(4) receptors, while
UDP was much less potent and efficacious. P2X receptor desensitisation had
only minor effect on the NO-mediated dilatations. In conclusion, both EDHF
and NO-mediated dilatation can be induced by activation of P2Y(1) and P2Y(2
)/P2Y(4) receptors. P2X receptor stimulation of smooth muscle cells selecti
vely counteracts the dilatory effect of EDHF. (C) 2000 Elsevier Science B.V
. All rights reserved.